The p53 protein in its natural state, sometimes called “the guardian of the genome,” is a front-line protector against cancer. But the mutant form appears in 50 percent or more of human cancers and in 80 percent of triple-negative breast cancers. It actively blocks cancer suppressors. Researchers at the University of Houston Rice University have …